TrialMedical oncology (Northwood, London, England)2012

High-dose homoharringtonine versus standard-dose daunorubicin is effective and safe as induction and post-induction chemotherapy for elderly patients with acute myeloid leukemia: a multicenter experience from China.

Bin-Tao Huang et al.PubMed ↗Publisher ↗

No numbers read from the abstract.